Veru

$Veru(VERU)$
VERU received FDA clarity supporting enobosarm plus GLP-1 RA as a combination obesity therapy, with incremental fat loss accepted as a primary endpoint; following positive Phase 2b QUALITY results showing preserved lean mass and physical function, Veru will i...

$Veru(VERU)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001042167-25-000066  Size: 5 KB 网页链接

$Veru(VERU)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001042167-25-000067  Size: 5 KB 网页链接

$Veru(VERU)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001042167-25-000070  Size: 5 KB 网页链接

$Veru(VERU)$ DEF 14A Other definitive proxy statements Accession Number: 0001140361-26-002671  Act: 34  Size: 4 MB 网页链接

$Veru(VERU)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001042167-25-000068  Size: 5 KB 网页链接

$Veru(VERU)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001042167-25-000072  Size: 5 KB 网页链接

$Veru(VERU)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001193125-25-321663  Act: 34  Size: 250 KB 网页链接

$Veru(VERU)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001437749-25-038089  Act: 34  Size: 9 MB 网页链接

$Veru(VERU)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001437749-25-038096  Act: 33  Size: 228 KB 网页链接

$Veru(VERU)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001042167-25-000069  Size: 5 KB 网页链接

$Veru(VERU)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001042167-25-000065  Size: 5 KB 网页链接

$Veru(VERU)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001042167-25-000071  Size: 5 KB 网页链接

$Veru(VERU)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001140361-26-002673  Act: 34  Size: 7 MB 网页链接